About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Mechanical Microvascular Protection is Not Needed with the Right Pharmacological Projection
By
Tim Fischell
17 Videos
0 views
May 4, 2010
Comments
2
Login to view comments.
Click here to Login
Recommended
AUTOPLAY
ON
14:39
Lankenau
Management of AF patients with ACS
Feat.
P. Kowey,
D. Ice
15:40
ACC 2022 Conference Coverage
ACC 2022: Triple Therapy - When to Use and How Long
Feat.
D. Kumbhani
57:30
McMaster University Department of Medicine
Five Things Every Internist Should Know About Anticoagulants
Feat.
S. Mithoowani
31:10
Insights from 2024 ACP Annual Meeting
ACP 2024 Insights: Acute Coronary Syndromes - Evaluation, Diagnosis …
Feat.
D. Berg
21:51
Cedars Sinai
Treating Stenosis or Ischemia Does Not Improve Outcomes: Medical The…
Feat.
W. Boden
19:47
Complex Coronary Cases
Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Us…
Feat.
U. Baber
34:40
Icahn School of Medicine at Mount Sinai
Peri-Operative Management of Anticoagulation
Feat.
A. Dunn
20:50
Salim Virani
Aspirin for Primary Prevention
15:41
UCLA Health
Anticoagulation in ECLS - To Bleed, or Not to Clot...
Feat.
A. Young
20:06
Canadian Collaborative Research Network
Stable CAD: ASA Alone, Prolonged DAPT or Low-Dose Rivaroxaban?
Feat.
M. Sabatine
12:46
AHA 2022 Conference Coverage
AHA 2022 Debate: Should CABG Be Level IIB for Improving Survival Com…
Feat.
F. Bakaeen
15:13
Cardiometabolic Health Congress (CMHC)
Dual Pathway Inhibition in the Cardiometabolic Patient: How Effectiv…
Feat.
D. Bhatt
16:34
AHA 2022 Conference Coverage
AHA 2022: Bivalirudin With a Post-PCI High-Dose Infusion versus Hepa…
Feat.
G. W. Stone
33:50
Houston Methodist DeBakey Heart and Vascular Center
Left Ventricular Thrombosis: An Overview
Feat.
Y. Saleh
11:50
TCT 2023 Insights
TCT 2023 Insights: Where Do Antithrombotics Fit In?
Feat.
M. Bonaca
12:53
Scottsdale Interventional Forum 2018
What is the Optimal DAPT Duration?
Feat.
R. Yeh
45:37
Cedars Sinai
Eliquis: Alternative Anticoagulation for HeartMate 3 Ventricular Ass…
Feat.
M. Slaughter
15:14
Cardiometabolic Health Congress (CMHC)
PAD in Patients with (a Risk of) Cardiometabolic Disease: What Is th…
Feat.
D. Bhatt
19:28
James Douketis
Perioperative Considerations for Anticoagulation With Mechanical Dev…
16:55
Scottsdale Interventional Forum 2015
PCI Pharmacology in 2015: Choosing the Right Antiplatelet & Anti…
Feat.
S. Bailey
